Skip to main content

Table 2 Parameters among the studied groups

From: Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients

Variables Fold change

The studied groups

  

HCC

N = 40

HCV

N = 30

Control

N = 30

U-test

p-value

AFP

 Mean ± SD

290.2 ± 202.7

3.38 ± 1.36

1.12 ± 0.44

3.81

0.0011

 Median

42.5

3

1

4.11

0.0012

 Range

3.66–1306

2–5

0.5–1.9

3.97

0.023

CK-1

 Mean ± SD

1.61 ± 1.82

1.44 ± 1.36

0.44 ± 0.27

0.08

0.741

 Median

1.1

1.11

0.34

2.76

0.0062

 Range

0.07–6.86

0.09–5.2

0.11–1

2.58

0.013

GPC-3

 Mean ± SD

2.09 ± 1.44

1.65 ± 0.79

0.60 ± 0.25

0.52

0.611

 Median

2.29

1.62

0.62

2.43

0.022

 Range

0.35–4.92

0.41–3.03

0.29–1.15

3.24

0.0013

ADAM-8

 Mean ± SD

1.04 ± 0.61

0.79 ± 0.54

0.57 ± 0.51

.06

0.291

 Median

0.87

0.60

0.42

2.37

0.022

 Range

0.27–2.64

1.0–1.61

0.08–1.87

0.73

0.473

HGF

 Mean ± SD

6.91 ± 6.42

4.13 ± 4.48

2.45 ± 2.49

0.93

0.351

 Median

4.30

2.83

1.62

1.85

0.072

 Range

0.11–18.38

0.13–16

0.27–8

0.99

0.323

MDK

 Mean ± SD

3.78 ± 4.69

2.47 ± 1.42

1.13 ± 0.37

0.10

0.921

 Median

1.93

2.07

1.31

1.20

0.232

 Range

0.22–17.18

0.57–6.06

0.57–1.62

2.87

0.0043

  1. 1 comparison of HCC group with HCV group
  2. 2 comparison of HCC group with control group
  3. 3 comparison of HCV group with control group